Business
Gene-Editing Startup Raises Funding and Licenses Chinese Deal
A new gene-editing startup has raised $230 million in funding and negotiated a licensing deal with a Chinese company.
Coverage timeline — 1 article
STAT News
A new gene-editing startup negotiated contracts with a Chinese company, raised $230 million in funding, and executed a reverse-merger with a preexisting biotech company.
2026-06-23 11:30 UTC